Europe - FRA:PTP - DE000A40AEG0 - Common Stock
The current stock price of PTP.DE is 1.762 EUR. In the past month the price increased by 4.88%. In the past year, price decreased by -61.7%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
EL.PA | ESSILORLUXOTTICA | 41.16 | 129.38B | ||
ESL.DE | ESSILORLUXOTTICA | 41.03 | 128.97B | ||
1EL.MI | ESSILORLUXOTTICA | 40.82 | 128.29B | ||
2U3.DE | ALCON INC | 25.48 | 32.72B | ||
CBHD.DE | COLOPLAST-B | 30.05 | 16.11B | ||
AFW.DE | ALIGN TECHNOLOGY INC | 13.57 | 7.89B | ||
GENT.OL | GENTIAN DIAGNOSTICS ASA | 20.82 | 863.52M | ||
GBT.PA | GUERBET | 10.99 | 176.45M | ||
ALCJ.PA | CROSSJECT | N/A | 104.19M | ||
AFME.PA | AFFLUENT MEDICAL SA | N/A | 58.24M | ||
SVS.MI | SVAS BIOSANA SPA | 8.25 | 47.15M |
Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 64 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.
PENTIXAPHARM HOLDING AG
Robert-Roessle-Strasse 10
Berlin BERLIN DE
Employees: 64
Phone: 493094893220
The current stock price of PTP.DE is 1.762 EUR. The price increased by 2.44% in the last trading session.
The exchange symbol of PENTIXAPHARM HOLDING AG is PTP and it is listed on the Deutsche Boerse Ag exchange.
PTP.DE stock is listed on the Deutsche Boerse Ag exchange.
5 analysts have analysed PTP.DE and the average price target is 11.95 EUR. This implies a price increase of 578.46% is expected in the next year compared to the current price of 1.762. Check the PENTIXAPHARM HOLDING AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
PENTIXAPHARM HOLDING AG (PTP.DE) has a market capitalization of 43.70M EUR. This makes PTP.DE a Nano Cap stock.
PENTIXAPHARM HOLDING AG (PTP.DE) currently has 64 employees.
PENTIXAPHARM HOLDING AG (PTP.DE) has a support level at 1.71 and a resistance level at 1.79. Check the full technical report for a detailed analysis of PTP.DE support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PTP.DE does not pay a dividend.
PENTIXAPHARM HOLDING AG (PTP.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.52).
ChartMill assigns a technical rating of 1 / 10 to PTP.DE. When comparing the yearly performance of all stocks, PTP.DE is a bad performer in the overall market: 98.11% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to PTP.DE. No worries on liquidiy or solvency for PTP.DE as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months PTP.DE reported a non-GAAP Earnings per Share(EPS) of -0.52.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -23.13% | ||
ROE | -28.29% | ||
Debt/Equity | 0 |
5 analysts have analysed PTP.DE and the average price target is 11.95 EUR. This implies a price increase of 578.46% is expected in the next year compared to the current price of 1.762.